NEW YORK, April 3, 2024 /PRNewswire/ — The global molecular diagnostics market size is estimated to grow by USD 7722.71 mn from 2023 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 5.96% during the forecast period. Asia held the largest share of the global market in 2022, and the market in the region is estimated to witness an incremental growth of 34%.
For more insights on the historic (2017 – 2021) and forecast market size (2023-2027) – Request a sample report to understand more about this market- Download a FREE Sample Report in minutes!
Asia is expected to play a pivotal role in propelling the global molecular diagnostics market
Geographic Landscape:
The Molecular Diagnostics Market in Asia experienced significant growth in 2022, driven by the region’s dominance in global healthcare markets and the increasing demand for advanced diagnostic technologies. Technologies such as DNA and RNA analysis, biomarker sequencing, and clinical molecular diagnostics have become essential tools in detecting and monitoring infectious diseases like COVID-19, dengue, tuberculosis, and hepatitis. The growing middle-class population and healthcare expenditures have fueled the demand for molecular diagnostics, making Asia a popular destination for medical tourism. Key developments in the industry include agreements between diagnostics companies and regulatory bodies for Emergency Use Authorizations, and the increasing incidence of diseases like prostate and lung cancer leading to a surge in genetic testing. Some European countries, such as Spain and Italy, have also shown strong growth in the molecular diagnostics market, driven by the IVD industry and the rising cases of obesity and HPV-related diseases. Market share analysis indicates the dominance of molecular diagnostic companies in this sector, with ongoing assay developments and diagnostic companies expanding their offerings to meet the growing demand.
Research Analysis
The Molecular Diagnostics Market is a significant segment of the healthcare industry, driven by innovation and technological advancements in laboratory testing. This market encompasses the analysis of genetic material, including DNA and RNA, to detect diseases and provide precise diagnosis. Biomarkers play a crucial role in molecular diagnostics, enabling early detection and personalized treatment plans. The market growth is fueled by the increasing demand for clinical molecular tests and the expansion of genomics and pathology services. Precision medicine and sequencing technologies are revolutionizing disease detection and treatment, leading to a burgeoning market size and industry growth. The molecular diagnostics industry is poised to make a substantial impact on healthcare diagnosis and research.
Market Drivers
The molecular diagnostics market continues to innovate, driven by increased awareness of early disease detection and personalized treatment options in oncology and other clinical applications. POC (Point of Care) molecular diagnostic products are leading the charge, delivering rapid and accurate results for a wide range of diseases and biomarkers. Technological advancements, such as polymerase chain reaction (PCR) techniques and next-generation sequencing, are expanding the diagnostic capabilities of laboratories and healthcare providers. With the approval of new molecular diagnostic tools and techniques, the diagnostic market is poised for significant growth in Europe, particularly in countries like Spain and Italy. The IVD (In Vitro Diagnostics) industry is experiencing a surge in cases, fueled by developments in genomics and diagnostics technology. Molecular testing is becoming an essential component of healthcare, enabling precise analysis of DNA and RNA for effective disease treatment and population screening.
Market Overview
The Molecular Diagnostics Market is a significant sector in the healthcare industry, characterized by the application of diagnostic techniques based on the molecular and genetic analysis of diseases. This market encompasses various technologies such as Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and Microarray. The market is driven by factors including the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and technological advancements in molecular diagnostics. In 2020, the global molecular diagnostics market size was valued at USD 22.3 billion and is projected to grow at a CAGR of 11.2% from 2021 to 2028. Key players in this market include Roche Diagnostics, Thermo Fisher Scientific, and Qiagen. The market is segmented by product type, application, and end user. The major applications of molecular diagnostics include infectious diseases, genetic disorders, and cancer. The end users of molecular diagnostics include hospitals, clinics, research institutions, and academic and government organizations. The market is also witnessing the emergence of point-of-care molecular diagnostics, which offer rapid and accurate results, making them ideal for resource-limited settings and remote locations. The future of molecular diagnostics lies in the integration of artificial intelligence and machine learning algorithms to enhance the accuracy and efficiency of diagnostic tests.
To understand more about this market- Download a FREE Sample Report in minutes!
Key Topics Covered:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Vendor Landscape
11 Vendor Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
